Exploring Doxycycline's Impact on C difficile Infections: An In-Depth Interview With Kari A. Mergenhagen, PharmD, BCPS, BCIDP

Kari A. Mergenhagen, PharmD, BCPS, BCIDP, discusses the potential of doxycycline in reducing C difficile infections among hospitalized patients with pneumonia. This interview delves into doxycycline's influence on patients with a prior C difficile history, demographic generalizability, exclusion criteria, and concerns regarding antibiotic resistance.

Related Keywords

New York ,United States ,American ,Karia Mergenhagen , ,Veterans Affairs ,Infection In Patients Hospitalized With Community ,Adobe Stock ,Western New York Healthcare System ,American Journal ,C Difficile ,C Diff ,Doxycycline ,Antibiotic Resistance ,Amr ,Health Care ,